1. Adam, A., Ciorbaru, R., Petit, J.-F., and Lederer, E., 1972, Isolation and properties of a macromolecular, water-soluble, immunoadjuvant fraction from the cell wall of Mycobacterium smeg matis, Proc. Natl. Acad. Sci. USA 69:851.
2. Adam, A., EUouz, F., Ciorbaru, R., Petit, J.-F., and Lederer, E., 1975, Peptidoglycan adjuvants Minimal structure required for activity, Z. Immunitaetsforsch. 149:341
3. Adam, A., Souvannavong, V., and Lederer, E., 1978, Nonspecific MIF-like activity induced by the synthetic immunoadjuvant N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP), Biochem. Biophys. Res. Commun. 85:684.
4. Adam, A., Petit, J.-F., Lefrancier, P., and Lederer, E., 1981, Muramyl peptides: Chemical structure, biological activity and mechanism of action, Mol. Cell. Biochem. 41:27.
5. Adams, D. O., and Marino, P. A., 1981, Evidence of a multistep mechanism of cytolysis by BCG-activated macrophages: The interrelationship between the capacity for cytolysis, target binding and secretion of cytolytic factor, J. Immunol. 126:981.